1
|
Kristensen VA, Opheim R, Perminow G, Huppertz-Hauss G, Detlie TE, Lund C, Andersen S, Olsen BC, Johansen I, Medhus AW, Vatn S, Brackmann S, Olbjørn C, Rove J, Henriksen M, Løvlund EE, Bengtson MB, Aabrekk TB, Tønnessen T, Vikskjold FB, Yassin H, Frigstad SO, Hasund A, Høie O, Schmidt K, Cetinkaya RB, Torp R, Skogestad E, Holm HK, Ahmad TR, Hovde Ø, Ystrøm CM, Aballi B, Sagosen A, Pedersen A, Dahler S, Pallenschat J, Ricanek P, Høivik ML. Inflammatory bowel disease in South-Eastern Norway III (IBSEN III): a new population-based inception cohort study from South-Eastern Norway. Scand J Gastroenterol 2021; 56:899-905. [PMID: 34154494 DOI: 10.1080/00365521.2021.1922746] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
BACKGROUND AND AIM Modern treatment strategies for inflammatory bowel disease (IBD) are postulated to change the natural disease course. Inception cohort studies are the gold standard for investigating such changes. We have initiated a new population-based inception cohort study; Inflammatory bowel disease in South Eastern Norway III (IBSEN III). In this article, we describe the study protocol and baseline characteristics of the cohort. METHODS IBSEN III is an ongoing, population-based observational inception cohort study with prospective follow-up. Adult and pediatric patients with suspected IBD in the South-Eastern Health Region of Norway (catchment area of 2.95 million inhabitants in 2017), during the 3-year period from 2017 to 2019, were eligible for inclusion. Comprehensive clinical, biochemical, endoscopic, demographic, and patient-reported data were collected at the time of diagnosis and throughout standardized follow-up. For a portion of the patients, extensive biological material was biobanked. RESULTS The study included 2168 patients, of whom 1779 were diagnosed with IBD (Crohn's disease: 626, ulcerative colitis: 1082, IBD unclassified: 71). In 124 patients, there were subtle findings indicative of, but not diagnostic for, IBD. The remaining 265 patients were classified as symptomatic non-IBD controls. CONCLUSION We have included patients in a comprehensive population-based IBD cohort from a catchment population of 2.95 million, and a unique biobank with materials from newly diagnosed and treatment-naïve IBD patients and symptomatic non-IBD controls. We believe this cohort will add important knowledge about IBD in the years to come.
Collapse
Affiliation(s)
- Vendel A Kristensen
- Department of Gastroenterology, Oslo University Hospital, Oslo, Norway.,Unger-Vetlesen Institute, Lovisenberg Diaconal Hospital, Oslo, Norway
| | - Randi Opheim
- Department of Gastroenterology, Oslo University Hospital, Oslo, Norway.,Department of Nursing Science, Institute of Health and Society, University of Oslo, Oslo, Norway
| | - Gøri Perminow
- Pediatric Department, Oslo University Hospital, Oslo, Norway
| | | | - Trond Espen Detlie
- Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway.,Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - Charlotte Lund
- Department of Gastroenterology, Oslo University Hospital, Oslo, Norway.,Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - Svend Andersen
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway.,Department of Paediatrics, Vestfold Hospital Trust, Tønsberg, Norway
| | - Bjørn C Olsen
- Department of Gastroenterology, Telemark Hospital, Skien, Norway.,Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - Ingunn Johansen
- Department of Health Sciences, Østfold University college, Halden, Norway
| | - Asle W Medhus
- Department of Gastroenterology, Oslo University Hospital, Oslo, Norway
| | - Simen Vatn
- Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway.,Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - Stephan Brackmann
- Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway.,Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - Christine Olbjørn
- Department of Paediatric and Adolescent Medicine, Akershus University Hospital, Lørenskog, Norway
| | - Jon Rove
- Department of Paediatric and Adolescent Medicine, Akershus University Hospital, Lørenskog, Norway
| | - Magne Henriksen
- Department of Gastroenterology, Østfold Hospital Trust, Grålum, Norway
| | | | | | | | - Tor Tønnessen
- Department of Gastroenterology, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway
| | - Florin Berge Vikskjold
- Department of Pediatric and Adolescent medicine, Drammen Hospital Vestre Viken Hospital Trust
| | - Hussain Yassin
- Department of Pediatrics, Telemark Hospital, Skien, Norway
| | - Svein Oskar Frigstad
- Department of Medicine, Baerum Hospital, Vestre Viken Hospital Trust, Gjettum, Norway
| | - Audun Hasund
- Department of Medicine, Sorlandet Hospital Kristiansand, Kristiansand, Norway
| | - Ole Høie
- Department of Internal Medicine, Sørlandet Sykehus Arendal, Arendal, Norway
| | - Katharina Schmidt
- Department of Pediatric and Adolescent Medicine, Sørlandet Sykehus Arendal, Arendal, Norway
| | | | - Roald Torp
- Medical Department, Innlandet Hospital Trust, Hamar, Norway
| | - Erik Skogestad
- Medical Department, Innlandet Hospital Trust, Lillehammer, Norway
| | | | - Tahir Riaz Ahmad
- Department of Medicine, Lovisenberg Diakonale Sykehus, Oslo, Norway
| | - Øistein Hovde
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway.,Department of Medicine, Innlandet Hospital Trust, Gjøvik, Norway
| | | | - Batool Aballi
- Pediatric Department, Innlandet Hospital Trust, Elverum, Norway
| | - Arnt Sagosen
- Department of Medicine, Kongsberg Hospital, Vestre Viken Hospital Trust, Kongsberg, Norway
| | - Aina Pedersen
- Department of Medicine, Kongsvinger Hospital, Kongsvinger, Norway
| | - Stein Dahler
- Department of Medicine, Notodden Hospital, Notodden, Norway
| | - Jens Pallenschat
- Department of Medicine, Sørlandet Hospital Flekkefjord, Flekkefjord, Norway
| | - Petr Ricanek
- Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway
| | - Marte Lie Høivik
- Department of Gastroenterology, Oslo University Hospital, Oslo, Norway.,Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| |
Collapse
|
2
|
Eskeland SL, Brunborg C, Seip B, Wiencke K, Hovde Ø, Owen T, Skogestad E, Huppertz-Hauss G, Halvorsen FA, Garborg K, Aabakken L, de Lange T. First quality score for referral letters in gastroenterology-a validation study. BMJ Open 2016; 6:e012835. [PMID: 27855107 PMCID: PMC5073635 DOI: 10.1136/bmjopen-2016-012835] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
OBJECTIVE To create and validate an objective and reliable score to assess referral quality in gastroenterology. DESIGN An observational multicentre study. SETTING AND PARTICIPANTS 25 gastroenterologists participated in selecting variables for a Thirty Point Score (TPS) for quality assessment of referrals to gastroenterology specialist healthcare for 9 common indications. From May to September 2014, 7 hospitals from the South-Eastern Norway Regional Health Authority participated in collecting and scoring 327 referrals to a gastroenterologist. MAIN OUTCOME MEASURE Correlation between the TPS and a visual analogue scale (VAS) for referral quality. RESULTS The 327 referrals had an average TPS of 13.2 (range 1-25) and an average VAS of 4.7 (range 0.2-9.5). The reliability of the score was excellent, with an intra-rater intraclass correlation coefficient (ICC) of 0.87 and inter-rater ICC of 0.91. The overall correlation between the TPS and the VAS was moderate (r=0.42), and ranged from fair to substantial for the various indications. Mean agreement was good (ICC=0.47, 95% CI (0.34 to 0.57)), ranging from poor to good. CONCLUSIONS The TPS is reliable, objective and shows good agreement with the subjective VAS. The score may be a useful tool for assessing referral quality in gastroenterology, particularly important when evaluating the effect of interventions to improve referral quality.
Collapse
Affiliation(s)
| | - Cathrine Brunborg
- Research Support Services, Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway
| | - Birgitte Seip
- Department of Medicine, Vestfold Hospital Trust Tønsberg, Tønsberg, Norway
| | - Kristine Wiencke
- Department of Medicine, Vestre Viken Hospital Trust Bærum, Drammen, Norway
| | - Øistein Hovde
- Department of Gastroenterology, Innlandet Hospital Trust Gjøvik, Gjøvik, Norway
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - Tanja Owen
- Department of Gastroenterology, Østfold Hospital Kalnes, Kalnes, Norway
| | - Erik Skogestad
- Department of Medicine, Innlandet Hospital Trust Lillehammer, Lillehammer, Norway
| | - Gert Huppertz-Hauss
- Department of Gastroenterology, Telemark Hospital Trust Skien, Skien, Norway
| | - Fred-Arne Halvorsen
- Department of Medicine, Vestre Viken Hospital Trust Drammen, Drammen, Norway
| | - Kjetil Garborg
- Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway
- Department of Health Economics and Health Management, University of Oslo, Oslo, Norway
| | - Lars Aabakken
- Department of Gastroenterology, Oslo University Hospital, Oslo, Norway
| | - Thomas de Lange
- Department of Medicine, Vestre Viken Hospital Trust Bærum, Drammen, Norway
- Cancer Registry of Norway, Oslo University Hospital, Oslo, Norway
| |
Collapse
|